文献
J-GLOBAL ID:201702243053503954
整理番号:17A0495892
ヘテロアリールジヒドロピリミジンに基づく臨床候補(GLS4)につながるB型肝炎ウイルスカプシド集合阻害剤の発見
Discovery of hepatitis B virus capsid assembly inhibitors leading to a heteroaryldihydropyrimidine based clinical candidate (GLS4)
著者 (11件):
Ren Qingyun
(Sunshine Lake Pharma Co., Ltd, Dong Guan 523808, China)
,
Ren Qingyun
(Anti-infection Innovation Department, New Drug Research Institute, HEC Pharma Group, Dong Guan 523871, China)
,
Liu Xinchang
(Sunshine Lake Pharma Co., Ltd, Dong Guan 523808, China)
,
Liu Xinchang
(Anti-infection Innovation Department, New Drug Research Institute, HEC Pharma Group, Dong Guan 523871, China)
,
Luo Zhonghua
(Sunshine Lake Pharma Co., Ltd, Dong Guan 523808, China)
,
Li Jing
(Sunshine Lake Pharma Co., Ltd, Dong Guan 523808, China)
,
Wang Chaolei
(Sunshine Lake Pharma Co., Ltd, Dong Guan 523808, China)
,
Wang Chaolei
(Anti-infection Innovation Department, New Drug Research Institute, HEC Pharma Group, Dong Guan 523871, China)
,
Goldmann Siegfried
(Sunshine Lake Pharma Co., Ltd, Dong Guan 523808, China)
,
Zhang Jiancun
(Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China)
,
Zhang Yingjun
(Sunshine Lake Pharma Co., Ltd, Dong Guan 523808, China)
資料名:
Bioorganic & Medicinal Chemistry
(Bioorganic & Medicinal Chemistry)
巻:
25
号:
3
ページ:
1042-1056
発行年:
2017年02月01日
JST資料番号:
W0556A
ISSN:
0968-0896
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)